The largest database of trusted experimental protocols

38 protocols using palbociclib

1

Generating Palbociclib-Resistant MCF-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MCF-7 was purchased in 2017 to 2018 from the Chinese Academy of Science Committee Type Culture Collection Cell Bank (Shanghai, China). MCF-7 cells were cultured in DMEM (Dulbecco's modified Eagle's medium) high glucose supplemented with 10% fetal bovine serum (FBS) and 100 units/ml of penicillin and 100 units /ml of streptomycin. The MCF-7 cells were maintained in a humidified atmosphere with 5% CO2 at 37 °C.
MCF-7 cells were initially cultured in medium containing 1 µM palbociclib (MedChem Express, Shanghai, China), and then cells were subcultured every 2-3 weeks in medium with increased concentrations of palbociclib (a 25% increase each time). Finally, the obtained cells grew exponentially in the presence of 30 µM palbociclib and were named as MCF-7pR.
+ Open protocol
+ Expand
2

Cell Viability Assay for Combination Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
In cell viability assay, 4000 cells per well were planted in 96-well plates and cells were exposed to different concentrations of agents in the following day. After 48-hour treatment, cell survival was assessed with the Cell Counting kit-8 in according to the recommended guideline (KeyGEN Biotech, Nanjing, China). Combination index (CI) values were calculated using CompuSyn software (ComboSyn, Inc., NJ, USA).
Palbociclib, Ribociclib, Abemaciclib, enzalutamide, Fulvestrant and Dihydrotestosterone (DHT) were obtained from MedChem Express, and Palbociclib was diluted in sterile water, DHT was dissolved in ethanol and others above were diluted in DMSO.
+ Open protocol
+ Expand
3

DNA Damage and Cell Cycle Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
H2DCFDA (Cat. number: HY-D0940), BrdU (Cat. number: HY-15910), palbociclib (Cat. number: HY-50767), ribociclib (Cat. number: HY-15777), niraparib (Cat. number: HY-10619), and olaparib (Cat. number: HY-10162) were from MedChem Express. Anti-phospho-γ-H2AX (Ser139) (Cat. number: 05-636) and FITC-conjugated anti-BrdU (Cat. number: MAB3262F) antibodies were from Millipore. Anti-Rb (ab181616), Anti-phospho-Rb (Ser780) (ab173289), Anti-histone H3 (ab1791), and Anti- PARP1 (ab191217) were from Abcam.
+ Open protocol
+ Expand
4

Cisplatin-Resistant Lung Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both human lung cancer cell lines (NCI-H23, and NCI-H2126) and HEK-293 cell line were procured from CAS-China and Microbix Biosystems Inc. respectively (Beijing, China). HEK-293 contains adenovirus (Adv) E1A-region for the replication of CRAd.
Cisplatin-resistant sublines, H23/CPR and H2126/CPR, were developed in our lab as described previously [24 (link)]. Afterward, all cancer cells were maintained in DMEM with 10% FBS and 2% of penicillin-streptomycin (HyCloneTM, Thermo Fisher Scientific, Waltham, MA USA USA). Doxorubicin (hydrochloride), cisplatin, elacridar, palbociclib, novobiocin, and probenecid were purchased from MedChemExpress (Shanghai, China) while puromycin was from Sigma-Aldrich. CRAd (incorporated with survivin promoter to regulate E1A region of Adv) was developed in our laboratory as described previously [35 (link)]. Ad-Luc expressing the firefly luciferase gene was used as a control.
+ Open protocol
+ Expand
5

Cytotoxicity Evaluation of CDK4/6 Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Abemaciclib was purchased from Selleckchem (Houston, TX, USA), palbociclib and ribociclib from MedChem Express (Monmouth Junction, NJ, USA). Daunorubicin, mitoxantrone, propidium iodide, RNAse A, NADP+, glucose-6-phosphate, and HPLC grade solvents were bought from Sigma-Aldrich (St. Louis, MO, USA). ABCB1 inhibitor LY335979 and Daunorubicinol were obtained from Toronto Research Chemicals (North York, ON, Canada), while ABCG2 inhibitor Ko143 was from Enzo Life Sciences (Farmingdale, NY, USA). Opti-MEM was acquired from Gibco BRL Life Technologies (Rockville, MD, USA). All other cell culture media and reagents were purchased from Sigma-Aldrich, Lonza (Walkersville, MD, USA), and PAA Laboratories (Pashing, Austria).
+ Open protocol
+ Expand
6

Chemotherapeutic Drug Combination Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gemcitabine (GEM), GSK-126, and decitabine (DEC) were purchased from Sigma Chemical Co (St. Louis, MO). Palbociclib (PAL) was acquired from MedChem Express (Monmouth Junction, NJ).
+ Open protocol
+ Expand
7

Autophagy Induction and Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 12-well tissue culture plates at 150,000 (Jurkat) or 200,000 (MOLM-13) cells per well. Cells were exposed to 0.1–0.5 µM etoposide (provided by the Jena University Hospital Pharmacy) for 6–48 h or to 25–400 nM palbociclib (MedChemExpress, Monmouth Junction, NJ, USA) for 48 h to induce autophagy. Cells were exposed to 2 mM 3-methyladenine (3-MA; Biomol, Hamburg, Germany) for 24 h or 48 h, or to 10 or 25 µM chloroquine (CQ; Enzo Life Sciences, Lörrach, Germany) for 1–48 h to inhibit autophagy.
+ Open protocol
+ Expand
8

Palbociclib and TAK-779 Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Palbociclib was purchased from MedChemExpress (MCE, CA, USA) [11 (link)]. Ten milligrams of Palbociclib was dissolved in 4.1323 ml sterilized triple-distilled water (concentration: 5 mmol/ml) and then was subpacked into 1.5 ml EP tubes and stored at -80°C. When used, the mother liquid was diluted with complete medium to 1 μΜ and 2 μM, respectively. Antagonists of CCR5, TAK-779, was purchased from MCE (CA, USA).
+ Open protocol
+ Expand
9

Western Blotting Techniques for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against GST (1:1000; Z-5, B-14, Santa Cruz), FLAG (1:1000; M2, Sigma), V5 (1:1000; D3H8Q, Cell Signaling), CAD (1:1000; A301-374A, Bethyl Laboratories), RelA (1:1000; 51-0500, Thermofisher), Pyruvate Carboxylase (1:1000; #66470, Cell Signaling, #49381, Cell Signaling), PDK3 (1:1000; AP7040a, Abcepta), Hexokinase 4 (1:1000; AP7901c, Abcepta), β-Actin (1:2000; 8H10D10, Cell Signaling), Phospho-CAD (1:1000; Ser1859, Cell Signaling), LANA (1:500; LN53, Abcam), vCyclin (1:500; 94B, Abcam), MYC(1:1000; 71D10, 9B11, Cell Signaling), CDK6 (1:1000; D4S8S, Cell Signaling) were purchased from the indicated suppliers. Polyclonal antibodies against KSHV vCyclin (1:500) and Phospho-CAD (Ser1900, 1:500) were generated by Genscript.
The glutamine analog 6-Diazo-5-oxo-L-norleucine (DON) was purchased from Sigma. JHU-083 (Ethyl 2-(2-Amino-4-methylpentanamido)-DON), Palbociclib, and N-(phosphonacetyl)-L-aspartic acid (PALA) were purchased from MedChemExpress. [U13C] Glucose and [Amide-15N] L-Glutamine were purchased from Cambridge Isotope Lab. Luciferin was purchased from Goldbio.
L-Lactate Assay Kit was purchased from Cayman Chemical. Cell proliferation Kit II, and Glutamate Assay Kit were purchased from Sigma. SYBR Green Master Mix was purchased from Bio-Rad and Genesee. Dual-Luciferase Reporter Assay System was purchased from Promega.
+ Open protocol
+ Expand
10

Autophagy Regulation in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical reagents were palbociclib (HY-50767), trametinib (HY-10999), CellCountingKit-8 (HY–K0301) and Chloroquine (HY-17589) from MedChemExpress. Antibodies were p62 (23214T), LC3 (12741T), Beclin-1 (3495T), ATG5 (Cat:12994T), AMPK (5831T), P-AMPK(2535T), mTOR (2983T), P-mTOR (2974T) and GAPDH (5174S) from Cell Signaling Technologies. Blots were probed with species-appropriate horseradish peroxidase–conjugated secondary antibodies (7076P2or7074P2, Cell Signaling Technologies) at a 1:2000 dilution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!